| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/JHH.2016.58 |
| P698 | PubMed publication ID | 27604661 |
| P50 | author | Athanase D. Protogerou | Q38800530 |
| Davide Agnoletti | Q88290090 | ||
| P2093 | author name string | Y Zhang | |
| J Blacher | |||
| M E Safar | |||
| A S Mansour | |||
| S Ouerdane | |||
| P2860 | cites work | Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 |
| A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 | ||
| Arterial stiffness and cardiovascular events: the Framingham Heart Study | Q33720064 | ||
| Measures of arterial stiffness in youth with type 1 and type 2 diabetes: the SEARCH for diabetes in youth study | Q33751587 | ||
| Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? | Q34154410 | ||
| Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes | Q35051910 | ||
| Determinants of vascular function in patients with type 2 diabetes | Q36376525 | ||
| Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes | Q37812790 | ||
| Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers | Q38008924 | ||
| Arterial stiffness, pulse pressure, and the kidney | Q38284050 | ||
| The impact of diabetes duration on left ventricular diastolic function and cardiovascular disease. | Q38465122 | ||
| Diabetes mellitus and renal failure: effects on large artery stiffness | Q43770780 | ||
| Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes | Q43982332 | ||
| Aortic stiffness and cardiovascular risk in type 2 diabetes | Q44060857 | ||
| Associations of metabolic variables with arterial stiffness in type 2 diabetes mellitus: focus on insulin sensitivity and postprandial triglyceridaemia | Q44380419 | ||
| The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study | Q44779306 | ||
| Sex differences in the effect of diabetes duration on coronary heart disease mortality | Q45287867 | ||
| Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. | Q51367336 | ||
| Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. | Q51377146 | ||
| Common carotid artery intima-media thickness is not increased but distensibility is reduced in normotensive patients with type 2 diabetes compared with control subjects. | Q51663843 | ||
| Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. | Q52331664 | ||
| Central hemodynamic modifications in diabetes mellitus | Q56977228 | ||
| Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes | Q61415536 | ||
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report | Q63694274 | ||
| Diabetes duration and cause-specific mortality in the Verona Diabetes Study | Q74150687 | ||
| Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes | Q80551797 | ||
| Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients | Q83276906 | ||
| A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with | Q86046161 | ||
| P433 | issue | 3 | |
| P921 | main subject | aorta | Q101004 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 189-194 | |
| P577 | publication date | 2016-09-08 | |
| P1433 | published in | Journal of Human Hypertension | Q15746469 |
| P1476 | title | Clinical interaction between diabetes duration and aortic stiffness in type 2 diabetes mellitus | |
| P478 | volume | 31 |
| Q88672779 | Associations between Type 2 Diabetes Mellitus and Arterial Stiffness: A Prospective Analysis Based on the Maine-Syracuse Study |
| Q61633716 | Central-to-brachial blood pressure amplification in type 2 diabetes: a systematic review and meta-analysis |
| Q49556660 | Concomitant Hypertension and Diabetes: Role of Aortic Stiffness and Glycemic Management |
| Q92255525 | Serum P-Cresyl Sulfate Is a Predictor of Central Arterial Stiffness in Patients on Maintenance Hemodialysis |
| Q38642771 | Serum resistin as an independent marker of aortic stiffness in patients with coronary artery disease. |
| Q91605829 | The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II |
Search more.